KINEVAC
Google image searchProduct monograph
Active ingredient
sincalide, 5 MCG/VIAL
DIN: 02228602
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Ethical
Company: BRACCO IMAGING CANADA
Date: 08-JUL-1998
ATC:
- V04 — DIAGNOSTIC AGENTS (ATC, ATC/DDD, )
- V04C — OTHER DIAGNOSTIC AGENTS (ATC, ATC/DDD)
- V04CC — Tests for bile duct patency (ATC, ATC/DDD)
- V04CC03 — SINCALIDE (ATC/DDD)
Reference brand drug: Kinevac
Pharmaceutical standard: MFR
